Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Thrombotic microangiopathy: Which Medications Are Safest? (88 Drugs Compared)

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

88 medications are used for Thrombotic microangiopathy, with 2,557 combined adverse event reports. The most reported drugs for Thrombotic microangiopathy are ECULIZUMAB and CAPLACIZUMAB-YHDP.

2,557
Total Reports
88
Drugs Used

All Medications for Thrombotic microangiopathy Ranked by Safety Reports

Drug Brand Reports Deaths (all) Hosp. (all) Death Rate
ECULIZUMAB SOLIRIS 1,312 4,626 12,421 10.5%
CAPLACIZUMAB-YHDP - 854 59 270 4.2%
RITUXIMAB Rituxan 99 28,910 54,631 16.2%
RAVULIZUMAB-CWVZ - 62 551 1,663 5.4%
METHYLPREDNISOLONE Medroloan II SUIK 56 12,828 26,552 20.1%
DEFIBROTIDE DEFITELIO 34 1,804 832 48.2%
PREDNISOLONE Prednisolone Sodium Phosphate 32 13,159 32,883 16.3%
PREDNISONE prednisone 30 22,555 57,772 14.2%
MYCOPHENOLATE MOFETIL Mycophenolate mofetil 23 13,776 25,831 18.4%
CYCLOPHOSPHAMIDE Cyclophosphamide 21 25,330 45,054 19.7%
HUMAN IMMUNOGLOBULIN G BIVIGAM 13 5,286 16,081 7.5%
SOLIRIS - 10 227 838 9.5%
DEXAMETHASONE Dexamethasone Sodium Phosphate 8 22,319 51,311 17.8%
CYCLOSPORINE Verkazia 6 9,332 14,257 13.7%
ETOPOSIDE Avopef 6 11,780 17,699 22.4%
RITUXIMAB-ABBS - 6 432 1,087 9.9%
RUXOLITINIB OPZELURA 6 10,908 14,461 16.0%
TACROLIMUS Tacrolimus 6 14,642 36,664 16.1%
THROMBOMODULIN ALFA - 5 37 22 51.4%

View all 88 drugs →

Most Reported Drugs for Thrombotic microangiopathy

#1 most reported
#2 most reported
#3 most reported